SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.26%1.54B | -1.38%1.57B | -8.47%1.47B | -23.83%6.11B | -14.97%1.4B | -25.11%1.51B | -26.45%1.6B | -26.73%1.61B | 4.60%8.02B | -21.88%1.65B |
Operating revenue | 2.26%1.54B | -1.38%1.57B | -8.47%1.47B | -23.83%6.11B | -14.97%1.4B | -25.11%1.51B | -26.45%1.6B | -26.73%1.61B | 4.60%8.02B | -21.88%1.65B |
Cost of revenue | 2.43%1.31B | -0.82%1.33B | -5.09%1.27B | -19.64%5.21B | -14.32%1.25B | -23.29%1.28B | -20.02%1.34B | -20.27%1.34B | 6.42%6.48B | -13.56%1.46B |
Gross profit | 1.30%234M | -4.33%243M | -25.28%201M | -41.40%906M | -20.00%152M | -33.81%231M | -48.37%254M | -47.77%269M | -2.40%1.55B | -55.08%190M |
Operating expense | -5.56%187M | 4.08%204M | -2.79%209M | 2.03%804M | 16.77%195M | -0.50%198M | 3.16%196M | -7.33%215M | -6.30%788M | -22.69%167M |
Selling and administrative expenses | -7.27%153M | 5.39%176M | -6.38%176M | -3.09%689M | -5.59%169M | 0.00%165M | -5.65%167M | -1.05%188M | -3.79%711M | -11.82%179M |
Research and development costs | -3.57%27M | 13.79%33M | 3.33%31M | -8.00%115M | 0.00%28M | -9.68%28M | -9.38%29M | -11.76%30M | -7.41%125M | -15.15%28M |
Other operating expenses | 40.00%7M | ---5M | 166.67%2M | ---- | ---- | 66.67%5M | ---- | -137.50%-3M | -45.45%-48M | -100.00%-40M |
Operating profit | 42.42%47M | -32.76%39M | -114.81%-8M | -86.54%102M | -286.96%-43M | -78.00%33M | -80.79%58M | -80.92%54M | 2.02%758M | -88.89%23M |
Net non-operating interest income expense | -40.00%-21M | -33.33%-20M | -5.56%-19M | -4.84%-65M | -6.25%-17M | 6.25%-15M | 6.25%-15M | -28.57%-18M | 7.46%-62M | -6.67%-16M |
Non-operating interest expense | 40.00%21M | 33.33%20M | 5.56%19M | 4.84%65M | 6.25%17M | -6.25%15M | -6.25%15M | 28.57%18M | -7.46%62M | 6.67%16M |
Other net income (expense) | -66.67%8M | 38.89%25M | -147.37%-9M | 6,100.00%62M | 103.13%1M | 100.00%24M | 125.00%18M | 46.15%19M | -99.82%1M | -106.50%-32M |
Gain on sale of security | ---- | ---- | ---- | 58.33%-5M | ---- | ---- | ---- | ---- | 57.14%-12M | ---- |
Earnings from equity interest | -83.33%5M | -35.71%18M | 58.33%19M | 23.88%83M | 8.33%13M | 42.86%30M | 47.37%28M | -20.00%12M | -53.15%67M | -52.00%12M |
Special income (charges) | 16.67%-5M | 50.00%-4M | -1,271.43%-82M | 79.78%-18M | 79.25%-11M | 50.00%-6M | 66.67%-8M | --7M | -120.89%-89M | -111.55%-53M |
-Less:Restructuring and merger&acquisition | -16.67%5M | -50.00%4M | 257.14%11M | -79.07%18M | -77.08%11M | -57.14%6M | -66.67%8M | ---7M | 115.00%86M | 700.00%48M |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.68%3M | ---- |
-Write off | --0 | --0 | --71M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Gain on sale of business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Other non- operating income (expenses) | --8M | 650.00%11M | --54M | -94.29%2M | -80.95%4M | ---- | -115.38%-2M | ---- | 20.69%35M | 162.50%21M |
Income before tax | -19.05%34M | -27.87%44M | -165.45%-36M | -85.80%99M | -136.00%-59M | -71.23%42M | -79.25%61M | -80.50%55M | -44.06%697M | -103.65%-25M |
Income tax | 44.44%39M | -53.57%13M | -281.82%-20M | -65.59%64M | -106.45%-2M | -10.00%27M | -56.92%28M | -81.67%11M | -2.62%186M | -65.56%31M |
Net income | -213.33%-17M | 22.58%38M | -113.86%-23M | -70.75%153M | 20.27%-59M | -86.96%15M | -87.19%31M | -30.83%166M | -52.63%523M | -112.19%-74M |
Net income continuous Operations | -133.33%-5M | -6.06%31M | -136.36%-16M | -93.15%35M | -1.79%-57M | -87.07%15M | -85.59%33M | -80.18%44M | -51.56%511M | -109.43%-56M |
Net income discontinuous operations | ---12M | 450.00%7M | -105.74%-7M | 883.33%118M | 88.89%-2M | --0 | -115.38%-2M | 577.78%122M | -75.51%12M | -238.46%-18M |
Minority interest income | 6.67%16M | 33.33%16M | 7.69%14M | -17.46%52M | -29.41%12M | 0.00%15M | -14.29%12M | -23.53%13M | 6.78%63M | 70.00%17M |
Net income attributable to the parent company | -33M | 15.79%22M | -124.18%-37M | -78.04%101M | 21.98%-71M | 0 | -91.67%19M | -31.39%153M | -55.98%460M | -115.24%-91M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -33M | 15.79%22M | -124.18%-37M | -78.04%101M | 21.98%-71M | 0 | -91.67%19M | -31.39%153M | -55.98%460M | -115.24%-91M |
Basic earnings per share | -0.19 | 18.18%0.13 | -126.19%-0.22 | -75.11%0.57 | 14.58%-0.41 | 0 | -90.09%0.11 | -20.00%0.84 | -51.99%2.29 | -117.39%-0.48 |
Diluted earnings per share | -0.19 | 18.18%0.13 | -126.51%-0.22 | -74.89%0.57 | 14.58%-0.41 | 0 | -90.00%0.11 | -20.19%0.83 | -51.91%2.27 | -117.58%-0.48 |
Dividend per share | 5.26%0.25 | 5.26%0.25 | 5.26%0.25 | 11.76%0.95 | 11.76%0.2375 | 11.76%0.2375 | 11.76%0.2375 | 11.76%0.2375 | 17.24%0.85 | 13.33%0.2125 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |